Division of Urology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Int J Environ Res Public Health. 2020 Jul 13;17(14):5026. doi: 10.3390/ijerph17145026.
(1) Background: The global threat of Coronavirus disease 2019 (COVID-19) continues. The diversity of clinical characteristics and progress are reported in many countries as the duration of the pandemic is prolonged. We aimed to perform a novel systematic review and meta-analysis focusing on findings about correlations between clinical characteristics and laboratory features of patients with COVID-19. (2) Methods: We analyzed cases of COVID-19 in different countries by searching PubMed, Embase, Web of Science databases and Google Scholar, from the early stage of the outbreak to late March. Clinical characteristics, laboratory findings, and treatment strategies were retrospectively reviewed for the analysis. (3) Results: Thirty-seven ( = 5196 participants) COVID-19-related studies were eligible for this systematic review and meta-analysis. Fever, cough and fatigue/myalgia were the most common symptoms of COVID-19, followed by some gastrointestinal symptoms which are also reported frequently. Laboratory markers of inflammation and infection including C-reactive protein (CRP) (65% (95% confidence interval (CI) 56-81%)) were elevated, while lymphocyte counts were decreased (63% (95% CI 47-78%)). Meta-analysis of treatment approaches indicated that three modalities of treatment were predominantly used in the majority of patients with a similar prevalence, including antiviral agents (79%), antibiotics (78%), and oxygen therapy (77%). Age was negatively correlated with number of lymphocytes, but positively correlated with dyspnea, number of white blood cells, neutrophils, and D-dimer. Chills had been proved to be positively correlated with chest tightness, lung abnormalities on computed tomography (CT) scans, neutrophil/lymphocyte/platelets count, D-dimer and CRP, cough was positively correlated with sputum production, and pulmonary abnormalities were positively correlated with CRP. White blood cell (WBC) count was also positively correlated with platelet counts, dyspnea, and neutrophil counts with the respective correlations of 0.668, 0.728, and 0.696. (4) Conclusions: This paper is the first systematic review and meta-analysis to reveal the relationship between various variables of clinical characteristics, symptoms and laboratory results with the largest number of papers and patients until now. In elderly patients, laboratory and clinical characteristics indicate a more severe disease course. Moreover, treatments such as antiviral agents, antibiotics, and oxygen therapy which are used in over three quarters of patients are also analyzed. The results will provide "evidence-based hope" on how to manage this unanticipated and overwhelming pandemic.
(1)背景:全球 2019 年冠状病毒病(COVID-19)的威胁持续存在。随着大流行持续时间的延长,许多国家报告了不同的临床特征和进展。我们旨在进行一项新的系统评价和荟萃分析,重点关注 COVID-19 患者临床特征与实验室特征之间相关性的研究结果。
(2)方法:我们通过检索 PubMed、Embase、Web of Science 数据库和 Google Scholar,从疫情早期到 3 月底,分析了不同国家的 COVID-19 病例。对临床特征、实验室发现和治疗策略进行回顾性分析。
(3)结果:本系统评价和荟萃分析共纳入 37 项(=5196 例参与者)COVID-19 相关研究。发热、咳嗽和疲劳/肌痛是 COVID-19 的最常见症状,其次是一些经常报告的胃肠道症状。炎症和感染的实验室标志物如 C 反应蛋白(CRP)升高(65%(95%置信区间 56-81%)),而淋巴细胞计数下降(63%(95%置信区间 47-78%))。治疗方法的荟萃分析表明,三种治疗方法在大多数患者中均有较高的应用率,包括抗病毒药物(79%)、抗生素(78%)和氧疗(77%)。年龄与淋巴细胞数呈负相关,与呼吸困难、白细胞数、中性粒细胞和 D-二聚体呈正相关。畏寒与胸闷、胸部 CT 异常、白细胞计数、中性粒细胞/淋巴细胞/血小板计数、D-二聚体和 CRP 呈正相关,咳嗽与咳痰呈正相关,肺部异常与 CRP 呈正相关。白细胞计数(WBC)也与血小板计数、呼吸困难和中性粒细胞计数呈正相关,其相关系数分别为 0.668、0.728 和 0.696。
(4)结论:这是第一篇系统评价和荟萃分析,揭示了迄今为止数量最多的文献和患者中临床特征、症状和实验室结果的各种变量之间的关系。在老年患者中,实验室和临床特征表明疾病过程更严重。此外,还分析了抗病毒药物、抗生素和氧疗等超过四分之三患者使用的治疗方法。研究结果将为如何应对这一意料之外和压倒性的大流行提供“循证希望”。